19-11447525-AGAGGAGGAGGAGGAGGAG-AGAG

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP3BS2

The NM_001289104.2(PRKCSH):​c.954_968delGGAGGAGGAGGAGGA​(p.Glu319_Glu323del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000152 in 1,583,934 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

PRKCSH
NM_001289104.2 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.27

Publications

11 publications found
Variant links:
Genes affected
PRKCSH (HGNC:9411): (PRKCSH beta subunit of glucosidase II) This gene encodes the beta-subunit of glucosidase II, an N-linked glycan-processing enzyme in the endoplasmic reticulum. The encoded protein is an acidic phosphoprotein known to be a substrate for protein kinase C. Mutations in this gene have been associated with the autosomal dominant polycystic liver disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
PRKCSH Gene-Disease associations (from GenCC):
  • polycystic liver disease 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001289104.2
BS2
High AC in GnomAd4 at 24 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRKCSHNM_001289104.2 linkc.954_968delGGAGGAGGAGGAGGA p.Glu319_Glu323del disruptive_inframe_deletion Exon 11 of 18 ENST00000677123.1 NP_001276033.1 K7ELL7B4DJQ5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRKCSHENST00000677123.1 linkc.954_968delGGAGGAGGAGGAGGA p.Glu319_Glu323del disruptive_inframe_deletion Exon 11 of 18 NM_001289104.2 ENSP00000503163.1 K7ELL7

Frequencies

GnomAD3 genomes
AF:
0.000161
AC:
24
AN:
149516
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0000494
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000663
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000213
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000297
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.000151
AC:
217
AN:
1434310
Hom.:
0
AF XY:
0.000146
AC XY:
104
AN XY:
712786
show subpopulations
African (AFR)
AF:
0.0000304
AC:
1
AN:
32884
American (AMR)
AF:
0.000119
AC:
5
AN:
42036
Ashkenazi Jewish (ASJ)
AF:
0.0000390
AC:
1
AN:
25668
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39096
South Asian (SAS)
AF:
0.0000238
AC:
2
AN:
84056
European-Finnish (FIN)
AF:
0.0000193
AC:
1
AN:
51680
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5546
European-Non Finnish (NFE)
AF:
0.000179
AC:
196
AN:
1094004
Other (OTH)
AF:
0.000185
AC:
11
AN:
59340
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
12
24
37
49
61
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000160
AC:
24
AN:
149624
Hom.:
0
Cov.:
0
AF XY:
0.000165
AC XY:
12
AN XY:
72900
show subpopulations
African (AFR)
AF:
0.0000492
AC:
2
AN:
40622
American (AMR)
AF:
0.0000663
AC:
1
AN:
15090
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3436
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5054
South Asian (SAS)
AF:
0.000214
AC:
1
AN:
4678
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10162
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000297
AC:
20
AN:
67348
Other (OTH)
AF:
0.00
AC:
0
AN:
2052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
370

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant, c.954_968del, results in the deletion of 5 amino acid(s) of the PRKCSH protein (p.Glu321_Glu325del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PRKCSH-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.3
Mutation Taster
=144/56
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3217229; hg19: chr19-11558340; API